Nearly half of Massachusetts doctors in busy specialties received payments or meals from pharmaceutical makers, but the practice appears to have had little impact on their prescribing habits, according to a new analysis. Aaron Kesselheim (Brigham and Women’s) is quoted.
Trending News
Search for Babesiosis Treatment Gets a New Map
New clues to help fight tick-borne disease
Can an AI ‘Co-Scientist’ Accelerate Cancer Research?
Nearly $7 million funds agentic AI tools to assist investigations into cancer’s most pressing…
First Large-Scale Study Shows How Doctors Use AI in Medicine
Which practitioners use artificial intelligence in the clinic, and what do they ask?